The DOI matches its Crossref record; 172 of the 176 references it cites were found in a registry or an index.
Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective
Open accessAbstract
Three dimensional (3D) printing as an advanced manufacturing technology is progressing to be established in the pharmaceutical industry to overcome the traditional manufacturing regime of 'one size fits for all'. Using 3D printing, it is possible to design and develop complex dosage forms that can be suitable for tuning drug release. Polymers are the key materials that are necessary for 3D printing. Among all 3D printing processes, extrusion-based (both fused deposition modeling (FDM) and pressure-assisted microsyringe (PAM)) 3D printing is well researched for pharmaceutical manufacturing. It is important to understand which polymers are suitable for extrusion-based 3D printing of pharmaceuticals and how their properties, as well as the behavior of polymer–active pharmaceutical ingredient (API) combinations, impact the printing process. Especially, understanding the rheology of the polymer and API–polymer mixtures is necessary for successful 3D printing of dosage forms or printed structures. This review has summarized a holistic materials–process perspective for polymers on extrusion-based 3D printing. The main focus herein will be both FDM and PAM 3D printing processes. It elaborates the discussion on the comparison of 3D printing with the traditional direct compression process, the necessity of rheology, and the characterization techniques required for the printed structure, drug, and excipients. The current technological challenges, regulatory aspects, and the direction toward which the technology is moving, especially for personalized pharmaceuticals and multi-drug printing, are also briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Viscosity ratio (η/ηo) of acetaminophen (APAP) in poly (ethylene oxide) (PEO) at different temperatures to determine the solubility of the drug. Reprinted with permission from M Yang, International Journal of Pharmaceutics, Published by Elsevier, 2011 [123].](https://figures.cochat.ai/paper-figures/5b0f2d6634994ae79cc2c2cbcb3eb075/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-7.jpg)
![Figure 8 The rheological characterization of the blends of different polymers [Affinisol 15LV (Aff15), Kollidon SR (KollSR), Eudragit EPO (EPO), hydroxypropyl cellulose (HPC)]. Constituent effect visualized with frequency sweep at the maximum processing temperature (200 °C). Reprinted with permission from K Ilyés, European Journal of Pharmaceutical Sciences, Published by Elsevier, 2019 [136].](https://figures.cochat.ai/paper-figures/b1ca4ae8602d4e64bbc6cbb3bfa0f28d/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-8.jpg)

![Figure 10 (a) Design of tablets, (b) the relationship between the target and achieved prednisolone dose, and (c) PVA based FDM 3D printed tablets having different dose strengths [56].](https://figures.cochat.ai/paper-figures/76d1606acd2449ce8e030af1e4501a72/polymers-for-extrusion-based-3d-printing-of-pharmaceuticals-a-holistic-figure-10.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“3D printing enables the fabrication of complex three-dimensional structures via computer-aided design, allows precise control over scaffold porosity, pore size, and microstructure, and facilitates accurate modulation of mechanical strength, and creates microstructures with graded porosity within a single scaffold [88–90].”
From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [88]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymers for 3D Printing and Customized Additive Manufacturing
Ligon, S. C., Liska, R., Stampfl, J., Gurr, M., & Mülhaupt, R. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00074 · Cited by 3,741
Farah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00112-0 · Cited by 2,613
Biomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Correlation of dynamic and steady flow viscosities
Cox, W. P., & Merz, E. H. (1958) · Journal of Polymer Science · doi:10.1002/pol.1958.1202811812 · Cited by 2,092
Personalized medicine: Time for one-person trials
Schork, N. J. (2015) · Nature · doi:10.1038/520609a · Cited by 1,223
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J., & Peppas, N. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.028 · Cited by 1,021
Awaja, F., Gilbert, M., Kelly, G., Fox, B., & Pigram, P. J. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.04.007 · Cited by 928
Three-Dimensional Printing: Rapid Tooling and Prototypes Directly from a CAD Model
Sachs, E., Cima, M., & Cornie, J. (1990) · CIRP Annals · doi:10.1016/s0007-8506(07)61035-x · Cited by 871
A new chapter in pharmaceutical manufacturing: 3D-printed drug products
Norman, J., Madurawe, R. D., Moore, C. M. V., Khan, M. A., & Khairuzzaman, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.001 · Cited by 810
Research works printed but not linked: 3
- Hardung, 2010, Combining HME & solubilization: Soluplus®—The solid solution, Drug Deliv. Technol., 10, 20
- Aho, J., Genina, N., Edinger, M., Botker, J.P., Baldursdottir, S., and Rantanen, J. (June, January 30). Drug-loaded poly (ε-caprolactone) for 3D printing of personalized medicine: A rheological study. Proceedings of the 25th Nordic Rheology Conference, Helsinki, Finland.
- Campbell, 2017, Pharma to table: 3-D printing and the regulatory future of home remedies, Conn. L. Rev. CONNtemplations, 49, 1
Cited by
3D Printing as a Promising Tool in Personalized Medicine
Vaz, V. M., & Kumar, L. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-020-01905-8 · Cited by 409
Seoane-Viaño, I., Januskaite, P., Alvarez-Lorenzo, C., Basit, A. W., & Goyanes, A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.027 · Cited by 357
Lignins as Promising Renewable Biopolymers and Bioactive Compounds for High-Performance Materials
Vasile, C., & Baican, M. (2023) · Polymers · doi:10.3390/polym15153177 · Cited by 251
“AM techniques, such as extrusion printing, direct ink writing, and fused deposition modeling, are suitable for printing pure lignin, lignin derivatives, or a combination with other polymers or monomers as fillers or additives necessary to create lignin-based printable feedstocks [278,279].”
MethodPolymeric drug delivery systems by additive manufacturing
Borandeh, S., van Bochove, B., Teotia, A., & Seppälä, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.022 · Cited by 254
“Like FDM, pressure assisted microsyringe (PAM, also known as semi-solid extrusion, SSE) relies on the computer-controlled preparation of a 3D structure with designed composition and architecture via the deposition of the materials in a layer-bylayer manner [96].”
BackgroundMethodInfluentialRecent advances in 3D printing technologies for wearable (bio)sensors
Kalkal, A., Kumar, S., Kumar, P., Pradhan, R., Willander, M., Packirisamy, G., Kumar, S., & Malhotra, B. D. (2021) · Additive Manufacturing · doi:10.1016/j.addma.2021.102088 · Cited by 232
Metadata
- Authors
- Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T.
- Affiliations
- North Carolina Agricultural and Technical State University (US)
- Virginia Commonwealth University (US)
- City University of New York (US)
- Massachusetts College of Pharmacy and Health Sciences (US)
- Corresponding author
- Azad, Mohammad A.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-02-03
- Volume
- 12
- Issue
- 2
- Pages
- 124
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC7076526
- OpenAlex
- W3003558240
- Semantic Scholar
- d0e7b174bfd4c9215a0e766bbf1923bb5c15a67d
- Cited by
- 356
- References
- 176
- Citations by year
- 2026: 38 · 2025: 44 · 2024: 48 · 2023: 73 · 2022: 66 · 2021: 57 · 2020: 28
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Engineering › Industrial and Manufacturing Engineering › Additive Manufacturing and 3D Printing Technologies
- Physical Sciences › Engineering › Building and Construction › Innovations in Concrete and Construction Materials
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- material extrusion, pharmaceutical 3D printing, fused deposition modeling, polymer rheology, controlled drug release
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective. https://app.cochat.ai/papers/10.3390/pharmaceutics12020124
- The paper
- Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020). Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective. Pharmaceutics. https://doi.org/10.3390/pharmaceutics12020124
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.